What is BlossomHill Therapeutics worth?
$413.1Mlast known valuation
BlossomHill Therapeutics last raised $84.2M in its Later Stage VC (Nov 2025).
Free account
See the evidence behind this price
- ·Post-money valuations for all 4 rounds
- ·The complete investor list — 10 names
- ·Watchlist + deal alerts for BlossomHill Therapeutics
Create free account
No card required
Funding history
4 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Nov 2025 | Later Stage VC | $84.2M | ▮ | ▮ |
| Dec 2023 | Later Stage VC | $88.6M | ▮ | ▮ |
| Mar 2021 | Later Stage VC | $71.0M | ▮ | ▮ |
| Dec 2020 | Seed Round | $2.0M | ▮ | ▮ |
How BlossomHill Therapeutics's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For BlossomHill Therapeutics, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked
- What is BlossomHill Therapeutics worth?
- BlossomHill Therapeutics's last known valuation is $413.1M.
- How much has BlossomHill Therapeutics raised?
- BlossomHill Therapeutics has raised $257.1M in total funding across 4 recorded rounds.
- When did BlossomHill Therapeutics last raise?
- BlossomHill Therapeutics last raised in Nov 2025 (Later Stage VC), raising $84.2M.